• 1
    Manthorpe R, Kirtava Z, Axell T, Henricsson V, Tabery H, Jacobsson L. Clinical and demographic data at the time of diagnosis for primary Sjögren's syndrome. In: HommaM, SugaiS, TojoT, MiyasakaN, AkizukiM, editors. Sjögren's syndrome: state of the art. New York: Kugler; 1994. p. 3679.
  • 2
    Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F, et al. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998; 57: 2915.
  • 3
    Smets EM, Garssen B, Bonke B, de Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 31525.
  • 4
    Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 101320.
  • 5
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000; 85: 46506.
  • 6
    Lovas K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebo BG, et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003; 88: 11128.
  • 7
    Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 13607.
  • 8
    Valtysdottir ST, Wide L, Hallgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001; 28: 125965.
  • 9
    Valtysdottir ST, Wide L, Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis 2003; 62: 8759.
  • 10
    Hartkamp A, Geenen R, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren's syndrome: a randomized controlled trial. Ann Rheum Dis 2008; 67: 917.
  • 11
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective connected action supported by the European community. Arthritis Rheum 1993; 3: 3407.
  • 12
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 13
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993; 2: 21727.
  • 14
    Sullivan M, Karlsson J, Ware J. The Swedish SF-36 health survey. I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995; 41: 134958.
  • 15
    Persson LO, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 health survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenburg. J Clin Epidemiol 1998; 51: 1095103.
  • 16
    Sullivan M, Karlsson J. The Swedish SF-36 health survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998; 51: 110513.
  • 17
    Altman DG. Practical statistics for medical research. London: Chapman and Hall; 1991.
  • 18
    Porola P, Virkki L, Przybyla BD, Laine M, Patterson TA, Pihakari A, et al. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in the salivary glands in Sjögren's syndrome. J Rheumatol 2008; 35: 222935.
  • 19
    Spaan M, Porola P, Laine M, Rozman B, Azuma M, Konttinen YT. Healthy human salivary glands contain a DHEA-S processing intracrine machinery, which is deranged in primary Sjögren's syndrome. J Cell Mol Med 2009; 13: 126170.
  • 20
    Feher KG, Feher T. Plasma dehydroepiandrosterone, dehydroepiandrosterone sulphate and androsterone sulphate levels and their interaction with plasma proteins in rheumatoid arthritis. Exp Clin Endocrinol 1984; 84: 197202.
  • 21
    Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 2418.
  • 22
    Weidler C, Struharova S, Schmidt M, Ugele B, Scholmerich J, Straub RH. Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: a prerequisite for local androgen deficiency. Arthritis Rheum 2005; 52: 17219.
  • 23
    Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 2003; 64: 95107.
  • 24
    Cutolo M, Straub RH. Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. Autoimmun Rev 2008; 7: 2238.